QRFP Neuron Stimulation for Hypometabolic State Induction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for inducing a hypometabolic state in diseased subjects, such as hibernation-like states, are not effectively clarified, particularly in non-hibernating animals, including humans, due to unclear neural mechanisms, and existing hypothermic therapies have limited effectiveness in adults and are not universally applicable.

Innovation Solution

Applying an excitatory stimulus to pyroglutamylated RFamide peptide (QRFP)-producing neurons in the anteroventral periventricular nucleus, medial preoptic area, and periventricular nucleus of the hypothalamus to induce a hibernation-like state, monitored through oxygen consumption and body temperature measurements, using an apparatus that calculates oxygen consumption and determines the presence of a hypometabolic or hibernation-like state.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Temperature

If hypothermic therapy is applied to adult subjects, then body temperature is reduced, but the therapeutic effectiveness is limited and does not improve prognosis compared with targeted temperature management

Engineering Contradiction:
Improvebody temperatureVSAvoidtherapeutic effectiveness
Core Design Contradiction:
TemperatureVSReliability

Solution Approach 1:

The invention changes the approach from passive hypothermic therapy to active hypometabolic state induction by stimulating QRFP-producing neurons, thereby altering the physiological parameters of metabolism and energy consumption rather than simply reducing temperature. This resolves the contradiction by achieving therapeutic effects through metabolic modulation while maintaining reliable temperature control.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention introduces QRFP-producing neurons as an intermediary mechanism to mediate between the therapeutic goal and the physiological response. By stimulating these specific neurons, the therapy achieves hypometabolic state induction more effectively than direct hypothermic approaches, resolving the reliability issue while maintaining temperature management.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If the neural mechanisms for inducing hibernation-like state are not clarified, then a hypometabolic state cannot be effectively induced in non-hibernating animals, but researching these mechanisms increases device and method complexity

Engineering Contradiction:
Improveability to induce hypometabolic stateVSAvoidcomplexity of induction method
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention extracts and targets the specific QRFP-producing neurons that control hibernation-like states, isolating this key neural pathway from the complex brain network. This allows effective induction of hypometabolic states in non-hibernating animals by focusing on a specific, identifiable neuron population rather than attempting to control the entire neural system.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention discovers that QRFP-producing neurons serve a universal function across different animal species, including non-hibernating mammals. By targeting this conserved neural pathway, the method achieves hypometabolic state induction universally across species without requiring species-specific complex mechanisms.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Measurement precision

If oxygen consumption is not monitored, then a hypometabolic state cannot be distinguished from death, but implementing monitoring increases device complexity

Engineering Contradiction:
Improveability to distinguish stateVSAvoidcomplexity of monitoring system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention implements oxygen consumption monitoring as a feedback mechanism to continuously assess the metabolic state of the subject. By measuring oxygen consumption levels and comparing them against established thresholds, the system can reliably distinguish between hypometabolic state and death, providing real-time feedback for therapeutic adjustment without requiring complex diagnostic procedures.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively delays disease progression and improves survival rates by inducing a controlled hypometabolic state, allowing for differentiation between a hibernation-like state and death based on oxygen consumption, providing a potential therapeutic approach for serious diseases.

Implementation Method 1

a measurement unit that measures an oxygen concentration of each exhaled air and inhaled air from the subject

Methodology Applied
Scientific EffectOxygen concentration measurement:

Implementation Method 2

a computation unit that calculates an oxygen consumption of the subject from an oxygen concentration difference between the exhaled air and the inhaled air from the subject

Methodology Applied
Scientific EffectOxygen consumption calculation:

Data Source

PatentUS20240180485A1Method and device for inducing hypometabolic state in subject with disease
Publication Date: 2024.06.06 RIKEN CO LTD
  • US20240180485A1 patent drawing
  • US20240180485A1 patent drawing
  • US20240180485A1 patent drawing

AI summary

The present invention provides a method for inducing a hibernation-like state and an apparatus therefor. According to the present invention, provided is a method for decreasing a theoretical setpoint temperature of body temperature and a feedback gain of heat generation in a subject or a method for inducing a hibernation-like state in a subject, the method being a chemical and/or physical method including providing an excitatory stimulus to a pyroglutamylated RFamide peptide (QRFP)-producing neuron. According to the present invention, an apparatus used to practice this method is also provided.